PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
CCL2 3,560 Target Target CXCL10 2,386 530 0.18 -0.81 0.22 0.85
CXCL11 526 Target Target CXCL4/PF4 9 3 0.04 -0.81 0.33 0.76
Cancer 1,053,491 Disease Target Equilibrative Nucleoside Transporter 1 211 71 0.00 -0.81 0.34 0.58
BMP-2B 18 Target Target BMP-4 1,255 6 0.04 -0.81 0.33 0.74
Tubulin Beta-1 Chain 3 Target Target Inosine-5'-Monophosphate Dehydrogenase 261 1 0.04 -0.81 0.33 0.76
CCL3 1,427 Target Target CXCL4/PF4 9 3 0.03 -0.82 0.33 0.72
Dpdpe 1,204 Drug Target CTAP-3 6 2 0.02 -0.82 0.33 0.72
Mu Opioid Receptor 4,576 Target Target CTAP-3 6 2 0.01 -0.82 0.33 0.68
Cancer 1,053,491 Disease Target CHK1 2,044 681 0.01 -0.82 0.33 0.60
Kadsulignan L 3 Drug Target Platelet Activating Factor 9,915 1 0.01 -0.82 0.33 0.65
BMP-2B 18 Target Target Collagen 138,882 6 0.00 -0.82 0.33 0.61
Calmodulin 25,240 Target Target Tubulin Beta-1 Chain 3 1 0.00 -0.82 0.33 0.63
Non Small Cell Lung Cancer 28,563 Disease Target Alk Tyrosine Kinase Receptor 3 1 0.00 -0.82 0.33 0.63
Atacand (Candesartan Cilexetil)- FDA 3 Drug Target Renin 43,456 1 0.00 -0.82 0.33 0.62
Lung Cancer 91,416 Disease Target Alk Tyrosine Kinase Receptor 3 1 0.00 -0.82 0.33 0.60
Shock 134,031 Disease Target Tubulin Beta-1 Chain 3 1 0.00 -0.82 0.33 0.59
Carcinoma 433,099 Disease Target Heat Shock Protein Hsp 90-Beta 3 1 0.00 -0.82 0.33 0.57
CCL2 3,560 Target Target CXCL10/IP-10 114 37 0.06 -0.82 0.32 0.75
Epidermal Growth Factor Receptor 24,772 Target Target EGF 27,487 4,679 0.18 -0.82 0.19 0.82
Cancer 1,053,491 Disease Target AKT2 873 284 0.01 -0.82 0.33 0.59
BMP-6 386 Target Target BMP-4 1,255 101 0.15 -0.82 0.26 0.83
CCN5 57 Target Target CYR61 539 17 0.10 -0.82 0.30 0.81
CD4 112,219 Target Target CD154 1,512 477 0.04 -0.83 0.32 0.67
Infection 766,637 Disease Target CRG-2 41 13 0.00 -0.83 0.32 0.57
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Target Bivalirudin 891 5 0.04 -0.83 0.31 0.75
Ovarian Cancer 33,996 Disease Target Kallikrein-8 19 6 0.01 -0.83 0.32 0.64
Epigen 27 Target Target Epiregulin 291 8 0.09 -0.83 0.30 0.81
Cancer 1,053,491 Disease Target Glutathione S-Transferase Theta-1 70 22 0.00 -0.83 0.31 0.57
Cancer 1,053,491 Disease Target Epiregulin 291 91 0.01 -0.83 0.31 0.58
BMP-6 386 Target Target BMP-7 1,112 95 0.15 -0.83 0.25 0.84
AACT 109 Target Target Alpha-1 AntiChymotrypsin 1,460 31 0.08 -0.84 0.28 0.78
4-1BB Ligand 135 Target Target CD137 474 33 0.13 -0.84 0.24 0.84
Cancer 1,053,491 Disease Target Urokinase-Type Plasminogen Activator 3,939 1,166 0.02 -0.84 0.30 0.60
Des (1-3) IGF-I 191 Target Target Des (1-6) IGF-II 18 5 0.09 -0.84 0.28 0.81
Cancer 1,053,491 Disease Target BRK 236 70 0.00 -0.84 0.30 0.57
Epidermal Growth Factor Receptor 24,772 Target Target Epigen 27 8 0.01 -0.84 0.30 0.65
Endostatin 1,599 Target Target Angiostatin K1-3 17 5 0.03 -0.84 0.29 0.73
CCL2 3,560 Target Target CXCL2 750 192 0.12 -0.84 0.26 0.80
Epidermal Growth Factor Receptor 24,772 Target Target beta-Cellulin 17 5 0.01 -0.84 0.29 0.65
Cancer 1,053,491 Disease Target CAPG 85 25 0.00 -0.84 0.29 0.57
Cancer 1,053,491 Disease Target beta-Cellulin 17 5 0.00 -0.84 0.29 0.56
Diabetes 332,602 Disease Target Adiponectin 11,994 3,433 0.05 -0.84 0.29 0.66
BMX 185 Target Target BTK 1,263 49 0.10 -0.84 0.26 0.80
Antithrombin 13,773 Target Target D-Dimer 6,185 1,337 0.14 -0.84 0.22 0.81
Abciximab (ReoPro)- FDA 7 Drug Target Eptifibatide 772 2 0.03 -0.84 0.29 0.73
Cancer 1,053,491 Disease Target EPHB4 329 94 0.01 -0.85 0.29 0.58
CD31/PECAM1 7 Target Target CD34 24,598 2 0.00 -0.85 0.29 0.64
Carcinoma 433,099 Disease Target AP2M1 7 2 0.00 -0.85 0.29 0.57
Cancer 1,053,491 Disease Target AP2M1 7 2 0.00 -0.85 0.29 0.56
Cancer 1,053,491 Disease Target CXCL14/BRAK 7 2 0.00 -0.85 0.29 0.56